Delivery Order SPE2DB20D2001-SPE2DB25FPLJW

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,094.07 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product, with a period of performance through November 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,882.98 firm fixed price delivery order is for the supply of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product. The contract has a completion date of November 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.87 firm fixed-price delivery order is for the supply of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of April 4, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,317.93, is for the delivery of JATENZO 237 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of June 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,094.07 firm fixed-price contract is for the delivery of JATENZO 237 MG CAPSULE 120S, a prescription medication. The contract has an ultimate completion date of October 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,154.01 firm fixed-price delivery order is for the supply of 120 units of the medication JATENZO 237 MG CAPSULE. The award has an ultimate completion date of May 7, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with...
This federal contract award is a delivery order valued at $4,817.16 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of JATENZO 237 MG CAPSULE 120S, a medical product, with a completion date of December 18, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,217.27, is for the supply of JATENZO 158 MG CAPSULE 120S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 13, 2025. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,492.24 firm fixed-price delivery order is for the supply of 120 capsules of the prescription drug JATENZO 198 MG. The contract has an ultimate completion date of May 14, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JATENZO 158 MG CAPSULE 120S, a specialty pharmaceutical product, with a ceiling value of $1,094.06. The contract has a firm fixed price pricing type and a period of performance through October 28, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB25FPLJW
    Delivery Order

This contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,251.77 firm fixed-price delivery order is for the supply of JATENZO 158 MG CAPSULE 120S, a pharmaceutical product. The contract has an ultimate completion date of October 31, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with any set-aside requirements, indicating open competition.

Generated 2/27/25, 12:26 PM